Literature DB >> 21565167

The activation of p38 MAPK primarily contributes to UV-induced RhoB expression by recruiting the c-Jun and p300 to the distal CCAAT box of the RhoB promoter.

Jiwon Ahn1, Jeong-Hae Choi, Misun Won, Chang-Mo Kang, Mi-Rang Gyun, Hee-Moon Park, Chun-Ho Kim, Kyung-Sook Chung.   

Abstract

The Ras-related small GTP-binding protein RhoB is rapidly induced in response to genotoxic stresses caused by ionizing radiation. It is known that UV-induced RhoB expression results from the binding of activating transcription factor 2 (ATF2) via NF-Y to the inverted CCAAT box (-23) of the RhoB promoter. Here, we show that the association of c-Jun with the distal CCAAT box (-72) is primarily involved in UV-induced RhoB expression and p38 MAPK regulated RhoB induction through the distal CCAAT box. UV-induced RhoB expression and apoptosis were markedly attenuated by pretreatment with the p38 MAPK inhibitor. siRNA knockdown of RhoB, ATF2 and c-Jun resulted in decreased RhoB expression and eventually restored the growth of UV-irradiated Jurkat cells. In the reporter assay using luciferase under the RhoB promoter, inhibition of RhoB promoter activity by the p38 inhibitor and knockdown of c-Jun using siRNA occurred through the distal CCAAT box. Immunoprecipitation and DNA affinity protein binding assays revealed the association of c-Jun and p300 via NF-YA and the dissociation of histone deacetylase 1 (HDAC1) via c-Jun recruitment to the CCAAT boxes of the RhoB promoter. These results suggest that the activation of p38 MAPK primarily contributes to UV-induced RhoB expression by recruiting the c-Jun and p300 proteins to the distal CCAAT box of the RhoB promoter in Jurkat cells.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21565167     DOI: 10.1016/j.bbrc.2011.04.121

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Transcriptional regulation of Rho GTPase signaling.

Authors:  Daniel R Croft; Michael F Olson
Journal:  Transcription       Date:  2011 Sep-Oct

Review 2.  Transcriptional and post-transcriptional regulation of the genes encoding the small GTPases RhoA, RhoB, and RhoC: implications for the pathogenesis of human diseases.

Authors:  Eirini Nomikou; Melina Livitsanou; Christos Stournaras; Dimitris Kardassis
Journal:  Cell Mol Life Sci       Date:  2018-03-02       Impact factor: 9.261

3.  ATF2 - at the crossroad of nuclear and cytosolic functions.

Authors:  Eric Lau; Ze'ev A Ronai
Journal:  J Cell Sci       Date:  2012-06-08       Impact factor: 5.285

4.  RhoB upregulation leads to either apoptosis or cytostasis through differential target selection.

Authors:  Laura A Marlow; Ilah Bok; Robert C Smallridge; John A Copland
Journal:  Endocr Relat Cancer       Date:  2015-07-23       Impact factor: 5.678

5.  The c-Jun/RHOB/AKT pathway confers resistance of BRAF-mutant melanoma cells to MAPK inhibitors.

Authors:  Audrey Delmas; Julia Cherier; Magdalena Pohorecka; Claire Medale-Giamarchi; Nicolas Meyer; Anne Casanova; Olivier Sordet; Laurence Lamant; Ariel Savina; Anne Pradines; Gilles Favre
Journal:  Oncotarget       Date:  2015-06-20

6.  Involvement of small G protein RhoB in the regulation of proliferation, adhesion and migration by dexamethasone in osteoblastic cells.

Authors:  Fei Diao; Kangyao Chen; Yan Wang; Yidong Li; Weidong Xu; Jian Lu; Yu-Xia Chen
Journal:  PLoS One       Date:  2017-03-21       Impact factor: 3.240

7.  Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer.

Authors:  James B Greenaway; Carl Virtanen; Kata Osz; Tamas Revay; Daniel Hardy; Trevor Shepherd; Gabriel DiMattia; Jim Petrik
Journal:  Oncotarget       Date:  2016-07-26

Review 8.  Role of Small GTPase RhoA in DNA Damage Response.

Authors:  Chibin Cheng; Daniel Seen; Chunwen Zheng; Ruijie Zeng; Enmin Li
Journal:  Biomolecules       Date:  2021-02-03

Review 9.  RhoB: Team Oncogene or Team Tumor Suppressor?

Authors:  Julia A Ju; Daniele M Gilkes
Journal:  Genes (Basel)       Date:  2018-01-30       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.